Thank you, Mr. Vice-Chair and distinguished members of the Parliament of Canada.
Genome Canada, a not-for-profit organization established in February 2000, was given the mandate by the Government of Canada to develop and implement a national strategy for supporting large-scale genomics and proteomics research projects for the benefit of all Canadians.
In the last eight years, our achievements have been many. Genome Canada has adopted a dynamic and systematic approach aimed at activities exclusively in the fields of genomics and proteomics, with a goal of achieving tangible and measurable results. This has allowed Canada to have pride of place among the world leaders in genomic and proteomic research in the fields of human health, the environment, agriculture, forestry, fisheries and the development of new technologies.
In addition, Genome Canada continues to play a leading international role in funding research projects to study the ethical, environmental, legal and social implications of genomic and proteomic research.
Since 2000, the Canadian federal government has invested $840 million in Genome Canada, to which has been added close to $1 billion in partnered co-funding and interest earnings.This additional funding was secured through the development of collaborative relationships and partnerships with private, public, and venture philanthropic organizations, both in Canada and abroad, to jointly finance large-scale genomics and proteomics research projects.
These investments have enabled Genome Canada to build a very strong organization that supports research projects, thus allowing Canadian genomics researchers to gain well-deserved respect and credibility in both the national and international arenas for cutting-edge research science that will have tremendous results for Canadian society and the global community.
Genome Canada's innovative business model is based on the funding and management of large-scale, multidisciplinary research projects that are evaluated by international peer committees. This model also allows researchers in all the areas I have previously mentioned access to groundbreaking scientific and technological platforms. The model also includes the creation of local centres of expertise in genomic research across Canada and the co-funding of projects with strategic research partners, both national and international.
Of high importance to Genome Canada is assuming the role of facilitator, drawing together industry, government departments and agencies, universities, research hospitals, and the public in support of large-scale genomics and proteomics research projects of strategic importance for Canada.
I will be pleased to take your questions.